G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

FMI Lead Program Integrator

Full-Time
No salary listed
Expert
Bachelor's
Bengaluru, Karnataka, India
In Person
Project & Program ManagementProgram Management

About the job

Requirements
  • At least 9 years of experience in engineering, service, quality, operations, program/project management, or a related field, including at least 5 years leading cross-functional projects or programs in a regulated environment.
  • Demonstrated experience managing schedules, risks, actions, resources, budgets, and stakeholder communication across complex programs.
  • Strong execution discipline, organisational capability, and ability to manage multiple concurrent priorities.
  • Effective written and verbal communication, including presenting program status, risks, and recommendations to leadership.
  • Ability to influence without direct authority in a global, matrixed organisation.
  • Fluent written and spoken English.
  • Proficiency with Microsoft 365 collaboration and reporting tools.
  • Ability to use approved digital and AI-enabled tools responsibly for productivity and decision support; software development expertise is not required.
Responsibilities
  • Lead assigned FMI and Recall programs from initiation through applicable F5/F6 closure milestones in accordance with approved Quality Management System procedures and program plans, maintaining accountability for execution, closure readiness, and program outcomes.
  • Establish and maintain integrated program plans, critical paths, milestones, resource forecasts, budget outlooks, governance mechanisms, and execution strategies, and align global stakeholders to deliver approved commitments.
  • Serve as the primary program leader across Engineering, Quality, Regulatory Affairs, Service, Supply Chain, Product, and regional stakeholders, driving decisions, approvals, issue resolution, and milestone achievement through influence and collaboration.
  • Identify risks, issues, dependencies, and changes; determine when leadership escalation is required; and present recommendations, recovery options, business impacts, and decision requirements.
  • Ensure completion of reconciliation activities, objective evidence, approvals, and regulatory-closure documentation; maintain audit-ready program records and compliance with approved procedures.
  • Lead a consistent Heartbeat operating rhythm using dashboards, program linearity, action ageing, visual management, and fact-based performance reviews; maintain accurate schedule, cost, quality, risk, and closure-readiness information as the program source of truth.
  • Coordinate execution priorities across Closure Analysts, consultants, and external partners; develop resource forecasts, manage utilisation, and identify productivity, cycle-time, and cost-to-serve improvements through Lean methodologies.
  • Provide concise, decision-oriented program updates, risk assessments, recommendations, and recovery plans to functional and business leadership, and drive programs to closure with minimal leadership intervention.
  • Identify and prioritise opportunities for workflow simplification, automation, analytics, and improved operational visibility across FMI/Recall processes.
  • Partner with Digital, Software, Data, AI, Cybersecurity, Quality, and Validation teams to define requirements and support solution deployment.
  • Champion adoption, training, value realisation, and responsible use of approved digital and AI-enabled solutions.
  • Track and communicate measurable operational benefits from digital initiatives.
  • Collaborate across Engineering, Quality, Regulatory, Service, Operations, Finance, Digital, business leadership, and relevant external partners to drive program execution and closure.
Desired Qualifications
  • Working knowledge of medical-device Quality Management Systems, product lifecycle, risk management, ISO 13485, ISO 14971, or applicable post-market regulatory expectations.
  • Experience supporting medical-device field actions, recalls, post-market programs, quality programs, or regulated service deployments.
  • Experience with Computed Tomography, Molecular Imaging, installed-base operations, or software/service deployment.
  • Experience overseeing consultants, contractors, closure analysts, or external engineering/service partners.
  • PMP, PMI-ACP, SAFe, Lean/Six Sigma, or equivalent program-management or continuous-improvement certification.
  • Experience supporting workflow automation, analytics, digital process improvement, or AI-enabled business initiatives.
  • Experience with program planning, action tracking, dashboards, or data-visualisation tools.
  • Familiarity with quality, service, product lifecycle, installed-base, or document-management systems.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.